Woon-Hong Yeo

Aug 8, 2024 | nature.com | Beomjune Shin |Youngjin Kwon |Yoon Jae Lee |Jimin Lee |Woon-Hong Yeo

AbstractPreclinical studies are crucial for developing amyotrophic lateral sclerosis drugs. Current FDA-approved drugs have been created by monitoring limb muscle function and histological analysis of amyotrophic lateral sclerosis model animals. Drug candidates for this disease have yet to be tested for bulbar-onset type due to the limitations of traditional preclinical tools: excessive animal use and discrete detection of disease progress.

Jul 4, 2024 | mdpi.com | Minki Kang |Woon-Hong Yeo

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.